Postural orthostatic tachycardia syndrome after COVID-19 vaccination: A systematic review
Abstract Background The global COVID-19 vaccination campaign, with 13.53 billion doses administered by early 2024, has significantly reduced severe illness and mortality. However, potential adverse effects, such as Postural Orthostatic Tachycardia Syndrome (POTS), have raised concerns. This systemat...
| 出版年: | BMC Cardiovascular Disorders |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2024-11-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s12872-024-04315-x |
